Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Efficacy and Tolerability of Lamotrigine in Borderline Personality Disorder: A Systematic Review and Meta-Analysis
1
x
$
30.00
Quick Inventory of Depressive Symptomatology—Self-Report (QIDS-SR)
1
x
$
0.00
Zung Self-Rating Depression Scale
1
x
$
0.00
Promoting the Discussion of the Beneficial Effects of Ketamine to Treat Refractory Depression
1
x
$
30.00
The History of Valproate in Clinical Neuroscience
1
x
$
30.00
DASS21
1
x
$
0.00
Patient Response Trajectories in Major Depressive Disorder
1
x
$
30.00
Cannabis Use and its Association with Psychological Disorders
1
x
$
30.00
Anxiety Disorders: Vast Progress but a Long Journey Ahead
1
x
$
0.00
View Cart
Checkout
Home
New Single-Isomer Compounds on the Horizon
“Anxiety Disorders: Vast Progress but a Long Journey Ahead” has been added to your cart.
View cart
New Single-Isomer Compounds on the Horizon
$
0.00
New Single-Isomer Compounds on the Horizon quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Mental Fitness
,
Mental Fitness Academic Supplement - VOL 7 No. 3 - Supp. 1
Tags:
joseph-gal
,
new-single-isomer-compounds
Description
Description
New Single-Isomer Compounds on the Horizon
By Joseph Gal, PhD
8-mf_suppl_gal2
Related products
The MentalFitness Interview: David Shaffer, FRCP, FRCPsych, on the Rise and Fall of the Teen Suicide Rate
$
0.00
Add to cart
Details
Economic Impacts of Anxiety Disorders
$
0.00
Add to cart
Details
The Development of Single-Isomer Molecules: Why and How
$
0.00
Add to cart
Details
Panic Disorder During Pregnancy
$
0.00
Add to cart
Details
Page load link
Go to Top
